Effect of cytomegalovirus infection on 1-year mortality rates among recipients of allogeneic bone marrow transplants

Clinical Infectious Diseases

Volumn 26, Issue 3, 1998, Pages 606-610

  Humar, Atul ^b   Wood, Serena ^b   Lipton, Jeff ^b   Messner, Hans ^b   Meharchand, Jacinta ^b   McGcer, Allison ^b   MacDonald, Kelly ^b   Mazzulli, Tony ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CYTOMEGALOVIRUS INFECTION; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE MYELOMA; ORGAN DONOR; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; VIRUS REACTIVATION;

EID: 0031969026     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514569     Document Type: Article

References (21)

1. Sable CA, Donowitz GR. Infections in bone marrow transplant recipients. Clin Infect Dis 1994;18:273-81.
2. Rowe JM, Ciobanu N, Ascensao J, et al. Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation: a report from the Eastern Cooperative Oncology Group (ECOG). Ann Intern Med 1994;120:143-58.
3. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986;153: 478-88.
4. Goodrich JM, Boeckh M, Bowden R. Strategies for the prevention of cytomegalovirus disease after marrow transplantation. Clin Infect Dis 1994;19:287-98.
5. Falagas ME, Snydman DR, Griffith J, et al. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. Ann Intern Med 1997;126:275-9.
6. Schmidt GM, Horak DA, Niland JC, et al. A randomized controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 1991; 324:1005-11.
7. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993;118:173-8.
8. Ringdén O, Horowitz MM, Gale RP, et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA 1993;270: 57-60.
9. Sutton L, Chastang C, Ribaud P, et al. Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients. Blood 1996;88: 358-65.
10. Valls A, Algara M, Marrugat J, Carreras E, Sierra J, Granena A. Risk factors for early mortality in allogeneic bone marrow transplantation. A multivariate analysis of 174 leukemia patients. Eur J Cancer 1993; 29:1523-8.
11. Bensinger WI, Buckner CD, Anasetti C, et al. Allogeneic marrow transplantation for multiple myeloma; an analysis of risk factors on outcome. Blood 1996;88:2787-93.
12. Kalhs P, Schwarzinger I, Anderson G, et al. A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 1995;86:2028-32.
13. Bacigalupo A, Tedone E, Isaza A, et al. CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CM V-antigen positive cell numbers with transplant-related mortality. Bone Marrow Transplant 1995;16:155-61.
14. Mazzulli T, Wood S, Chua R, Walmsley S. Evaluation of the digene hybrid capture system for detection and quantitation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients. J Clin Microbiol 1996;34:2959-62.
15. Proceedings from the 5th International Cytomegalovirus Conference. Stockholm, Sweden, May 21-24, 1995. Scand J Infect Dis Suppl 1995; 99:1-120.
16. Hibberd PL, Snydman DR. Cytomegalovirus infection in organ transplant recipients. Infect Dis Clin North Am 1995;9:863-77.
17. Grob JP, Grundy JE, Prentice HG, et al. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections. Lancet 1987;1:774-6.
18. Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988;109:783-8.
19. Paulin T, Ringdén O, Lönnqvist B. Faster immunological recovery after bone marrow transplantation in patients without cytomegalovirus infection. Transplantation 1985;39:377-84.
20. Paulin T, Ringdén O, Nilsson B, Lönnqvist B, Gahrton G. Variables predicting bacterial and fungal infections after allogeneic marrow engraftment. Transplantation 1987;43:393-8.
21. Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients. Blood 1995;86:3979-86.